WO2000012745A1 - Method for preparing (2r)-piperidine derivatives - Google Patents
Method for preparing (2r)-piperidine derivatives Download PDFInfo
- Publication number
- WO2000012745A1 WO2000012745A1 PCT/EP1999/006277 EP9906277W WO0012745A1 WO 2000012745 A1 WO2000012745 A1 WO 2000012745A1 EP 9906277 W EP9906277 W EP 9906277W WO 0012745 A1 WO0012745 A1 WO 0012745A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- general formula
- microorganisms
- pipecolinic acid
- amino
- reaction
- Prior art date
Links
- 0 C*C(CC=C=CC(*)[U])=N Chemical compound C*C(CC=C=CC(*)[U])=N 0.000 description 4
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/10—Nitrogen as only ring hetero atom
- C12P17/12—Nitrogen as only ring hetero atom containing a six-membered hetero ring
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
- C12P41/001—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by metabolizing one of the enantiomers
Definitions
- the present invention relates to a new process for the preparation of (2R) - piperidine derivatives of the general formulas
- R 1 is hydroxy, amino or C ,. -AIkoxy and R 4 is hydroxy or amino
- (2R) -piperidine derivatives of the general formula I are important synthesis building blocks for biologically active compounds, such as stimulants of growth hormone release (WO-A-9513069) or anti-anxiety agents (DE-A-37 02 943).
- EP-A-686 698 describes a biotechnological process for the production of S- ⁇ -aminocarboxylic acids, for example S- ⁇ -pipecolinic acid, by reacting the racemic RS- ⁇ -aminocarboxylic acid amides with microorganisms of the genera Klebsiella and Pseudomonas, and also the corresponding ones R- ⁇ -aminocarboxylic acid amides are obtained In order to prepare the R- ⁇ -aminocarboxylic acid amides, however, the S- ⁇ -aminocarboxylic acids have to be separated off using relatively complex processes
- JP-A-63 248 393 describes a process for the preparation of (R) -pipecolinic acid starting from racemic pipecolinic acid by means of microorganisms of the genera Pseudomonas, Kurthia or Alcaligenes. The long reaction times are disadvantageous in this process
- the object of the present invention is to eliminate these disadvantages and to provide a simple process for the preparation of (2R) -piperidine derivatives, with which high yields can be achieved and which is feasible on an industrial scale
- microorganisms which have the property of ⁇ -aminocarboxamides in foam of racemate or its optically active isomers of the general formula III,
- microorganisms wherein A together with -NH and -CH represent an optionally substituted 5- or 6-membered saturated heterocyclic ring as the only nitrogen source that can be used.
- Such microorganisms are known in the prior art and have already been described in detail in EP-A-686 698 Preferred microorganisms with the properties described above are microorganisms of the genera Klebsiella and Pseudomonas. Microorganisms of the species Pseudomonas putida, in particular those of the species Pseudomonas putida with the designation DSM 9923, and their functionally equivalent variants and mutants are particularly preferred
- microorganisms of the species Pseudomonas putida with the designation DSM 9923 were on 20 04 1 95 at the German Collection for Microorganisms and Cell Cultures GmbH (DSM). Mascherodeweg lb, D-38124 Braunschweig, deposited in accordance with the Budapest Treaty
- R "is hydroxyl, amino or d .c-alkoxy can decompose in the presence of trace elements and under aerobic conditions with ring cleavage and, in the case of microorganisms, can be used as the only source of carbon and energy. After a sufficient reaction time, usually after 1 to 48 hours, then there is little or no ring-shaped S- ⁇ -aminocarboxylic acid or other disruptive open-chain by-products such as S-2-aminoadipic acid in the reaction medium in the reaction medium.
- the (2R) -piperidine derivatives of the general formula I accumulated during the reaction
- R is hydroxy, amino or C
- C] - f -Aikoxy has the meaning of a straight-chain or branched alkoxy group with 1 to 6 C atoms here and below. Methoxy, ethoxy, propoxy, isopropoxy, butoxy, isobutoxy should be mentioned. tert-butoxy, pentoxy and its isomers and hexoxy and its isomers
- the enzymes for the cell-free system can be obtained by disrupting the microorganisms in a manner customary in the art. For example, the ultrasound, French press or lysozyme method can be used for this purpose. These cell-free enzymes can also be immobilized on a suitable carrier material
- trace elements are, for example, zinc, manganese, cobalt, copper, nickel, molybdenum, calcium, magnesium, boi.
- Zinc and manganese are preferred.
- Boron, iron and sulfur »emeinsa 'sge sets
- the most preferred substrates of the general formula II are (RS) -pipecolinic acid, (RS) -pipecolinic acid ethyl ester, (RS) -pipecolinic acid isopropyl ester and (RS) -pipecolinic acid amide
- Aerobic conditions are understood to mean culture conditions in which the microorganisms are supplied with oxygen. This can be experienced, for example, in shake culture by atmospheric oxygen or in submerged culture by blowing in molecular oxygen or atmospheric oxygen
- the reaction can be carried out without conventional cultivation directly by adding the microorganisms to (RS) -piperidine derivatives of the general formula II.
- the reaction can be carried out after conventional cultivation of the microorganisms with a suitable carbon and energy source Sugar.
- Carboxylic acids, sugar alcohols or amino acids can be used.
- sugars hexoses such as glucose or pentoses can be used
- glutamate can be used
- reaction is preferably carried out without customary cultivation directly by adding the microorganisms to (RS) -piperidine derivatives of the general Foimel II
- the microorganisms can use the (S) -isomer of the (RS) -piperidine derivative of the general formula II as the only carbon and energy source and as the only nitrogen source
- the medium customary in the art can be used as the medium for the process according to the invention, such as mineral salt media, for example the mineral salt medium according to Kulla et al (Arch Microbiol 135, 1-7. 1983), the media described in Table 1 or low-molar buffers such as 10 to 100 mM phosphate buffer to which the necessary trace elements have been added.
- the process is preferably carried out in the media according to Table 1
- the conditions are expediently chosen such that the S-isomer of the (RS) -piperidine derivatives of the formula II is preferably used by the microorganisms as a carbon and energy source.
- the medium therefore preferably does not contain any compounds other than compound II that are easily usable as a carbon and energy source links
- the reaction is carried out expediently with a single, repeated or continuous addition of (RS) -piperidine derivatives of the general formula II.
- the addition of (RS) -piperidine derivatives of the general formula II is carried out in such a way that the concentration is 30% by weight, preferably 10% by weight %, particularly preferably 5% by weight, not exceeded
- the pH of the medium is expediently in a range from 4 to 9, preferably from 6 to 8
- the reaction is expedient at a temperature of from 15 to 80 ° C., preferably from 25 to 40 ° C. by 'saw 1 -f
- (2R) -pipecolinic acid amide or (2R) -pipecolinic acid is obtained from (RS) -pipecolinic acid amide can be controlled, for example, via the reaction time.
- the (2R) initially Pipecolinic acid amide which can be isolated if necessary
- the acid is formed from the (2R) -pipecolinic acid amide.
- the reaction can be followed analytically, e.g. chromatographically. The same applies to the reaction of (RS) -pipecolinic acid esters, in which the (2R ) -Pipecolinic acid ester and then the acid accumulates
- the (2R) -piperidine derivatives of the general formula I preferably the (R) -pipecolinic acid, the (R) -pipecolinic acid amide and the (R) -pipecolinic acid ethyl and isopropyl esters, become very high to quantitative Yield obtained in the medium
- the (2R) -piperidine derivatives of the general formula I obtained in this way can be isolated by customary work-up methods such as, for example, by separating off the biomass, acidification, chromatography, electrodialysis or crystallization
- the course of the reaction can also be regulated via the supply of oxygen.
- the reaction is expedient until the (R) -pipecolinic acid amide or the like is accumulated (R) -pipecolinic acid esters as above described carried out under aerobic conditions and then the oxygenation adjusted, after which the acid is formed
- R has the meaning given above, which can be temporarily accumulated in the medium with increasing enantiomeric excess and, if appropriate, isolated. If the (R) -pipecolinic acid derivative according to formula VI is to be prepared from the (RS) -pipecolinic acid derivative according to formula V, it will after accumulation isolated If the (R) -pipecolinic acid according to formula IV is to be produced from the (RS) -pipecolinic acid derivative according to formula V, the reaction is expediently carried out under aerobic conditions until the accumulation of the (R) -pipecolinic acid derivative according to formula VI and then the oxygen supply is stopped
- reaction can be followed analytically, for example by chromatography Implementation should be stopped as soon as the accumulation of the (R) -p ⁇ pecol ⁇ nsaurede ⁇ ⁇ ats according to formula VI is reached
- Another component of the invention is the further implementation, the reduction, of the (2R) - Pipecolmsaurede ⁇ vate dei general formula VI to the (2R) -P ⁇ pe ⁇ d ⁇ nde ⁇ ⁇ aten of the general Foimel VII
- R is Hvdroxv or Amino
- an alkali metal hydride or an alkaline earth metal hydride such as, for example, is used as the reducing agent Potassium or
- the reduction is expediently carried out at a temperature of 0 to 100 ° C., preferably at the reflux temperature of the corresponding solvent
- the reduction can be carried out in a polar organic solvent, for example in an ethei. Diethyl ether, dipropylethei, tetrahydrofuran or 1,4-dioxane are suitable as ethers, for example
- the desired products of the general formula VII such as the (R) -2- (aminomethyl) p; per ⁇ d ⁇ n or the (R) -2- (hydroxymethyl) p ⁇ pe ⁇ d ⁇ n, can then be isolated by known processing methods Table 1
- Pseudomonas putida DSM 9923 was grown on medium 3 with 20 g / l glutamate overnight in the fermenter. At OD650 of 14, 1% (RS) -pipecolinic acid amide was added. According to GC analysis, after 2 hours there was practically enantiomerically pure (R) -pipecolinic acid amide before pipecolinic acid was not to prove
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002341554A CA2341554A1 (en) | 1998-08-26 | 1999-08-26 | Process for the preparation of (2r)-piperidine derivatives |
AU57415/99A AU5741599A (en) | 1998-08-26 | 1999-08-26 | Method for preparing (2r)-piperidine derivatives |
JP2000567728A JP2002523107A (en) | 1998-08-26 | 1999-08-26 | Method for producing (2R) -piperidine derivative |
EP99944524A EP1108053A1 (en) | 1998-08-26 | 1999-08-26 | Method for preparing (2r)-piperidine derivatives |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP98116061 | 1998-08-26 | ||
EP98116061.7 | 1998-08-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2000012745A1 true WO2000012745A1 (en) | 2000-03-09 |
Family
ID=8232514
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP1999/006277 WO2000012745A1 (en) | 1998-08-26 | 1999-08-26 | Method for preparing (2r)-piperidine derivatives |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1108053A1 (en) |
JP (1) | JP2002523107A (en) |
AU (1) | AU5741599A (en) |
CA (1) | CA2341554A1 (en) |
WO (1) | WO2000012745A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2348107A2 (en) | 2003-02-18 | 2011-07-27 | Metabolic Explorer | Method for preparing evolved micro-organisms, enabling the creation or modification of metabolic pathways |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS63248393A (en) * | 1987-04-02 | 1988-10-14 | Agency Of Ind Science & Technol | Production of d-pipecolic acid by microorganism |
EP0686698A2 (en) * | 1994-06-09 | 1995-12-13 | Lonza Ag | Biotechnological process for the production of cyclic S-alpha-aminocarboxylic acids and R-alpha-aminocarboxylic acid amides |
-
1999
- 1999-08-26 EP EP99944524A patent/EP1108053A1/en not_active Ceased
- 1999-08-26 AU AU57415/99A patent/AU5741599A/en not_active Abandoned
- 1999-08-26 WO PCT/EP1999/006277 patent/WO2000012745A1/en not_active Application Discontinuation
- 1999-08-26 JP JP2000567728A patent/JP2002523107A/en active Pending
- 1999-08-26 CA CA002341554A patent/CA2341554A1/en not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS63248393A (en) * | 1987-04-02 | 1988-10-14 | Agency Of Ind Science & Technol | Production of d-pipecolic acid by microorganism |
EP0686698A2 (en) * | 1994-06-09 | 1995-12-13 | Lonza Ag | Biotechnological process for the production of cyclic S-alpha-aminocarboxylic acids and R-alpha-aminocarboxylic acid amides |
Non-Patent Citations (3)
Title |
---|
DATABASE WPI Section Ch Week 198847, Derwent World Patents Index; Class B03, AN 1988-334671, XP002124625 * |
FRANZEN V: "Asymmetric catalysis of the intramolecular Cannizzaro reaction.", CHEMISCHE BERICHTE., vol. 90, 1957, pages 2036 - 2039, XP002124624, ISSN: 0009-2940 * |
MOCHIZUKI K ET AL: "Simultaneous Production of D-Pipecolic Acid and L-alpha-Aminoadipic Acid from DL-Pipecolic Acid Using a Microorganism", AGRICULTURAL AND BIOLOGICAL CHEMISTRY., vol. 52, no. 5, 1988, pages 1113 - 1116, XP002124623, ISSN: 0002-1369 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2348107A2 (en) | 2003-02-18 | 2011-07-27 | Metabolic Explorer | Method for preparing evolved micro-organisms, enabling the creation or modification of metabolic pathways |
Also Published As
Publication number | Publication date |
---|---|
AU5741599A (en) | 2000-03-21 |
EP1108053A1 (en) | 2001-06-20 |
JP2002523107A (en) | 2002-07-30 |
CA2341554A1 (en) | 2000-03-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69016739T2 (en) | Chiral azabicycloheptanones and process for their preparation. | |
DE69626820T2 (en) | REDUCTION OF KETONE GROUPS | |
DE3424440C2 (en) | ||
DE69221777T2 (en) | Fermentation process for the production of 2-keto-L-gulonic acid | |
US4474882A (en) | Microbiological process for the preparation of unsaturated dicarboxylic acids | |
DE3752086T2 (en) | Process for the production of optically active cyclopropanecarboxylic acid | |
DE69506900T2 (en) | ENZYMATIC PROCESS FOR PRODUCING CHIRAL ALPHA-TERTIARY CARBONIC ACID ESTERS | |
DE3217908C2 (en) | ||
EP0502525B1 (en) | Biotechnological process for the production of S-(+)-2,2-dimethylcyclopropanecarboxamide and R-(-)-2,2-dimethylcyclopropanecarboxylic acid | |
NZ333445A (en) | Process for obtaining enantiomerically enriched N-acylazetidine-2-carboxylic acids comprising the biotransformation of racemic N-acylazetidine-2-carboxylic acid ester with an enantiospecific enzyme | |
EP1095160B1 (en) | Method for producing (1r,4s)-2-azabicyclo 2.2.1 hept-5-en-3-on derivatives. | |
DE69908569T2 (en) | METHOD FOR PRODUCING FEXOFENADINE | |
DE69513827T2 (en) | METHOD FOR PRODUCING OPTICALLY ACTIVE ALPHA-SUBSTITUTED CARBONIC ACID DERIVATIVES | |
WO2000012745A1 (en) | Method for preparing (2r)-piperidine derivatives | |
DE602005002146T2 (en) | Process for the microbiological production of optically active 3-chloro-2-methyl-1,2-propanediol | |
DE69226942T2 (en) | METHOD FOR PRODUCING OPTICALLY ACTIVE NORBORNEOL | |
BG62056B1 (en) | Arylalkane acid separation | |
EP0271432B1 (en) | Racemate cleavage of 3-acyloxy-bicyclo[3.3.0]octan-7-on-2-carboxylic-acid esters by stereospecific enzymatic or microbiological acylate hydrolysis | |
EP0583687A2 (en) | Method for the preparation of substituted methoxyphenols and microorganisms therefore | |
DE60004763T2 (en) | Process for the preparation of (s) -3-halogeno-1,2-propanediol by Pseudomonas | |
DE60010013T2 (en) | Process for the preparation of optically active 1,2,4-butanetriol and optically active 3-hydroxy-gamma-butyrolactone by means of microorganisms | |
DE3878264T2 (en) | MONOACETYLATION OF DIOLES WITH A BIOCATALYZER MADE OF CORYNE BACTERIUM OXIDANS. | |
DE69018576T2 (en) | Process for the preparation of (+) - homopilopic acid. | |
DE69839248T2 (en) | PROCESS FOR THE PREPARATION OF INHIBITORS OF HMG-CoA REDUCTASE. | |
DE4328231C1 (en) | Process for the preparation of (L) -2-chloropropionic acid and its salts |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1999944524 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: PV2001-649 Country of ref document: CZ |
|
ENP | Entry into the national phase |
Ref document number: 2341554 Country of ref document: CA Ref country code: CA Ref document number: 2341554 Kind code of ref document: A Format of ref document f/p: F |
|
WWP | Wipo information: published in national office |
Ref document number: PV2001-649 Country of ref document: CZ |
|
WWP | Wipo information: published in national office |
Ref document number: 1999944524 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 09763541 Country of ref document: US |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWR | Wipo information: refused in national office |
Ref document number: 1999944524 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1999944524 Country of ref document: EP |